Alliance for Clinical Trials in Oncology: all 509 studies
Page 3 of 6. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerActive, not recruitingNCT04137107Phase 2/3
- Single Fraction Stereotactic Radiosurgery or Three to Five Fraction Stereotactic Radiosurgery in Treating Patients With Brain Metastasis That Has Been Removed by SurgeryActive, not recruitingNCT04114981Phase 3
- Genetic Testing in Guiding Treatment for Patients With Brain MetastasesActive, not recruitingNCT03994796Phase 2
- Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionActive, not recruitingNCT03927027Phase 3
- Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple MyelomaCompletedNCT03870633
- Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic AlterationsActive, not recruitingNCT03609216Phase 2
- Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502TerminatedNCT03609021
- Breast Cancer WEight Loss Study (BWEL Study)Active, not recruitingNCT02750826Phase 3
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsActive, not recruitingNCT02375204Phase 3
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
- Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyActive, not recruitingNCT01901094Phase 3
- Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT01838434Phase 1
- Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerCompletedNCT01821612Early Phase 1
- Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303CompletedNCT01664169
- Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular LymphomaCompletedNCT01644799Phase 1
- Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without TrastuzumabCompletedNCT01562288
- CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and ChemotherapyWithdrawnNCT01545687Phase 3
- Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung CancerCompletedNCT01517971
- Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202CompletedNCT01503619
- Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01497444Phase 1
- Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT01486602Phase 1
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerWithdrawnNCT01473303Phase 1/2
- Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation TherapyWithdrawnNCT01473290Phase 3
- Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin LymphomaCompletedNCT01429025Phase 1
- Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung CancerWithdrawnNCT01415739
- Study of Tissue Samples From Patients With Non-Small Cell Lung CancerCompletedNCT01414595
- Biomarkers in Tissue Samples From Older Women With Breast CancerTerminatedNCT01346579
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaCompletedNCT01334502Phase 1
- Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic CancerCompletedNCT01327794
- Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyCompletedNCT01294280
- Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic LeukemiaCompletedNCT01284010
- Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With KetoconazoleWithdrawnNCT01275651
- Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal CancerCompletedNCT01243372
- Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon CancerTerminatedNCT01167725Phase 3
- Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung CancerCompletedNCT01139944
- DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701CompletedNCT01057459
- Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871CompletedNCT01015963
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT01005368
- Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720CompletedNCT01004965
- Study of Tissue and Blood Samples From Patients With High-Grade GliomaCompletedNCT01004887
- Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical TrialActive, not recruitingNCT01004640
- Study of Tissue and Blood Samples From Patients With Low-Grade GliomaCompletedNCT01004523
- Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741CompletedNCT00991263
- Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202CompletedNCT00990873
- Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27CompletedNCT00968214
- Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001CompletedNCT00954655
- Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00951444Phase 2
- Study of Tumor Samples From Patients With Lung CancerCompletedNCT00900328
- Studying Tissue and Blood Samples From Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00900224
- Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung CancerCompletedNCT00899782
- Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral CancerWithdrawnNCT00899704
- Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030CompletedNCT00899535
- Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast CancerCompletedNCT00899509
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic SyndromesActive, not recruitingNCT00899223
- Biomarkers in Native American Women With Breast CancerCompletedNCT00898976
- Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00898924
- Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831CompletedNCT00898898
- Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583TerminatedNCT00898833
- Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107TerminatedNCT00898547
- Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00898456
- Genetics Study of Tissue Collected From Patients With Acute Myeloid LeukemiaStatus unknownNCT00898092
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor TherapiesCompletedNCT00897663
- Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581CompletedNCT00897429
- Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid LeukemiaCompletedNCT00897182
- Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344CompletedNCT00897026
- Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2CompletedNCT00896701
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaActive, not recruitingNCT00887146Phase 3
- Acute Pain Caused by Paclitaxel in Patients With CancerCompletedNCT00860041
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00787969Phase 1
- Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT00571740Phase 2
- Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerCompletedNCT00516698
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung CancerActive, not recruitingNCT00499330
- Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
- Collection of Patient-Reported Symptoms and Performance Status Via the InternetCompletedNCT00417040Not applicable
- Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerCompletedNCT00416689
- Assessing Older Patients With CancerCompletedNCT00416481
- Citalopram in Treating Postmenopausal Women With Hot FlashesCompletedNCT00363909Phase 3
- Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for CancerCompletedNCT00362986Phase 3
- Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or AnastrozoleCompletedNCT00316836
- Liposomal SN-38 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00311610Phase 2
- Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerCompletedNCT00275041Phase 2
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00268489Phase 2
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00265733Phase 2
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00227565Phase 2
- American Ginseng in Treating Patients With Cancer-Related FatigueCompletedNCT00182780Not applicable
- Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00117975Phase 2
- Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerCompletedNCT00115505
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00107510Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00107341Phase 2
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
- Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNCT00104754Phase 2
- Gefitinib in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00100945Phase 2
- Everolimus in Treating Patients With Stage IV MelanomaCompletedNCT00098553Phase 2
- Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or PelvisCompletedNCT00091351Phase 3
- Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for CancerCompletedNCT00091247Not applicable
- Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung CancerCompletedNCT00089310Not applicable
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00088998Phase 2
- Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone TherapyCompletedNCT00087399Phase 3
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNCT00086801Phase 2
← Alliance for Clinical Trials in Oncology overview and focus areas